Closed to Patient Entry

Date of activation: 11-Jan-2016
Date Step1 close: 24-Oct-2022

No

Phase 3
Randomized open label

EORTC Groups: 192 - All Groups: 420

Drug
Carboplatin, Cisplatin, Etoposide, Filgrastim, Ifosfamide, Paclitaxel, Pegfilgrastim

• Thomas Powles (Study Coordinator), Barts Health NHS Trust - St. Bartholomew'S Hospital, London
• Egle Venslovaite (Project Manager), EORTC Headquarters, Brussels
• Beatrice Fournier (Clinical Scientist), EORTC Headquarters, Brussels
• Ionela Stanciu (Clinical Operations Manager), EORTC Headquarters, Brussels
• Bart Meulemans (Data Manager), EORTC Headquarters, Brussels
• Anna Fleming (Pharmacovigilance Manager), EORTC Headquarters, Brussels
• Zara Nasir (Pharmacovigilance Manager), EORTC Headquarters, Brussels
• Laurens Vinckier (Pharmacovigilance Manager), EORTC Headquarters, Brussels
• Gilles Sarlet (Regulatory Affairs Manager), EORTC Headquarters, Brussels
• Katheline Vander Heggen (Regulatory Affairs Manager), EORTC Headquarters, Brussels
• Jessica Berger (Clinical Research Associate/Monitor), EORTC Headquarters, Brussels
• Luminita Copaceanu (Lead CRA), EORTC Headquarters, Brussels
• Salvatore Mazza (Lead CRA), EORTC Headquarters, Brussels
• Ilse Coppens (Clinical Operations Assistant), EORTC Headquarters, Brussels

• Testicular

• EORTC Genito-Urinary Cancers Group
• UNICANCER
• Cancer Trials Ireland
• Alliance
• Institute of Cancer Research - Clinical Trials & Statistics Unit
• The Australian and New Zealand Urogenital and Prostate

• APHP Sorbonne Univ - Hopital Tenon (PARIS, France)
• Arnold Palmer Hospital Haley Center for Children’s Cancer and Blood Disorders (Orlando, United States of America)
• Barts Health NHS Trust - St. Bartholomew'S Hospital (London, United Kingdom)
• CHU de Toulouse - Institut Claudius Regaud - IUCT oncopole (TOULOUSE, France)
• Cancer Center of Kansas (Wichita, United States of America)
• Centre Leon Berard (Lyon, France)
• Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin (Berlin, Germany)
• Dana-Farber/Harvard Cancer Center (Boston, United States of America)
• Eastern Health - Box Hill Hospital (Box Hill, Australia)
• Emory University/Winship Cancer Institute (Atlanta, United States of America)
• Fondazione IRCCS - Policlinico San Matteo (Pavia, Italy)
• Gemeinschaftsklinikum Mittelrhein gGmbH (Koblenz, Germany)
• Greenville Health System Cancer Institute-Eastside (Greenville, United States of America)
• Gustave Roussy (VILLEJUIF CEDEX, France)
• Hospital De La Santa Creu I Sant Pau (Barcelona, Spain)
• Hospital General Universitario Dr Morales Meseguer (Murcia, Spain)
• Hospital Universitario 12 De Octubre (Madrid, Spain)
• ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain)
• IRCCS - Fondazione Istituto Nazionale dei Tumori (Milano, Italy)
• Inselspital (Bern, Switzerland)
• Institut Jules Bordet (Anderlecht, Belgium)
• Institut Paoli-Calmettes (MARSEILLE CEDEX 09, France)
• Klinikum Nuernberg- Standort Nord (Nuernberg, Germany)
• Leeds Teaching Hospitals NHS Trust - St. James's University Hospital (Leeds, United Kingdom)
• Loma Linda University (Loma Linda, United States of America)
• M D Anderson Cancer Center (Houston, United States of America)
• Mayo Clinic (Rochester, United States of America)
• Medical College of Wisconsin (Milwaukee, United States of America)
• Memorial Sloan-Kettering Cancer Center - Memorial hospital (New York, United States of America)
• NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital (Glasgow, United Kingdom)
• Nottingham University Hospitals NHS Trust - City Hospital (Nottingham, United Kingdom)
• Ohio State University Cancer Center (Columbus, United States of America)
• Peter Maccallum Cancer Institute (Melbourne, Australia)
• Princess Alexandra Hospital - University Of Queensland (Woolloongabba, Brisbane, Australia)
• Rhode Island Hospital / Brown University (Providence, United States of America)
• Rigshospitalet (Copenhagen, Denmark)
• Roswell Park Cancer Institute (Buffalo, United States of America)
• Rotkreuzklinikum Muenchen (Muenchen, Germany)
• Royal Marsden Hospital - Sutton, Surrey (Surrey, United Kingdom)
• Royal Prince Alfred Hospital (Sydney, Australia)
• Saint Francis Cancer Center (Tulsa, United States of America)
• Saint Jude Children's Research Hospital (Memphis, United States of America)
• Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital (Sheffield, United Kingdom)
• Siteman Cancer center- St. Louis (St Louis, United States of America)
• St. James'S Hospital (Dublin, Ireland)
• The Christie NHS Foundation Trust (Manchester, United Kingdom)
• The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands)
• UCSF Helen Diller Family Comprehensive Cancer Center (San Francisco, United States of America)
• USC Norris Comprehensive Cancer Center (Los Angeles, United States of America)
• Univ. of Chicago Duchossois Center Advanced Medicine (Chicago, United States of America)
• UniversitaetsKlinikum Heidelberg - Head Hospital (Heidelberg, Germany)
• UniversitaetsSpital Zurich (Zurich, Switzerland)
• Universitaetsklinik Dusseldorf (Duesseldorf, Germany)
• Universitaetsklinikum - Essen (Essen, Germany)
• Universitaetsklinikum Carl Gustav Carus (TUD) (Dresden, Germany)
• Universitaetsklinikum Giessen und Marburg - Campus Marburg (Marburg, Germany)
• Universitaetsklinikum Hamburg-Eppendorf KE - University Cancer Center (Hamburg, Germany)
• Universitaetsklinikum Ulm (Ulm, Germany)
• University Hospital Southampton NHS Foundation Trust - Southampton General Hospital (Southampton, United Kingdom)
• University Of Pittsburgh Cancer Institute (Pittsburgh, United States of America)
• University of Oklahoma - Health Science Center (Oklahoma City, United States of America)
• University of Pennsylvania - Abramson Cancer Center (Philadelphia, United States of America)
• Vanderbilt Ingram Cancer Center - Breast Center (Nashville, United States of America)

http://clinicaltrials.gov/study/NCT02375204

NCT02375204

2014-003930-17